Cite
HARVARD Citation
Erbilgin, Y. et al. (2019). Deep sequencing of BCR-ABL1 kinase domain mutations in chronic myeloid leukemia patients with resistance to tyrosine kinase inhibitors. Leukemia & lymphoma. 60 (1), pp. 200-207. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Erbilgin, Y. et al. (2019). Deep sequencing of BCR-ABL1 kinase domain mutations in chronic myeloid leukemia patients with resistance to tyrosine kinase inhibitors. Leukemia & lymphoma. 60 (1), pp. 200-207. [Online].